RAPT Therapeutics's total assets for Q2 2025 were $178.41M, a decrease of -4.88% from the previous quarter. RAPT total liabilities were $14.00M for the fiscal quarter, a 37.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.